Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma

NCT04565327 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Hyperpolarized Carbon C 13 Pyruvate
PROCEDURE: Magnetic Resonance Imaging (MRI)

Sponsor

Zhen Wang, MD